LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 49.33 | 771.67 | 6421 | 6392 | 1.0044 | 1.0029 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 49.33 | 771.67 | 4617 | 6392 | 0.7222 | 0.7976 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 51.55 | 771.67 | 6860 | 6829 | 1.0044 | 1.0028 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 51.55 | 771.67 | 4955 | 6829 | 0.7255 | 0.8061 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 53.77 | 771.67 | 7317 | 7256 | 1.0084 | 1.0052 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 53.77 | 771.67 | 5191 | 7256 | 0.7154 | 0.8032 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 55.99 | 771.67 | 7698 | 7690 | 1.0010 | 1.0006 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 55.99 | 771.67 | 5446 | 7690 | 0.7082 | 0.8024 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 58.21 | 771.67 | 8081 | 8085 | 0.9994 | 0.9997 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 58.21 | 771.67 | 5676 | 8085 | 0.7020 | 0.8017 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 60.44 | 771.67 | 8441 | 8530 | 0.9895 | 0.9939 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 60.44 | 771.67 | 5914 | 8530 | 0.6933 | 0.7994 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 62.66 | 771.67 | 8781 | 8978 | 0.9780 | 0.9875 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 62.66 | 771.67 | 6090 | 8978 | 0.6783 | 0.7923 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 64.88 | 771.67 | 9193 | 9447 | 0.9731 | 0.9850 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 64.88 | 771.67 | 6331 | 9447 | 0.6702 | 0.7903 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 67.10 | 771.67 | 9529 | 9800 | 0.9723 | 0.9848 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 67.10 | 771.67 | 6563 | 9800 | 0.6697 | 0.7928 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 69.32 | 771.67 | 9775 | 10212 | 0.9572 | 0.9767 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 69.32 | 771.67 | 6647 | 10212 | 0.6509 | 0.7823 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 71.54 | 771.67 | 10100 | 10532 | 0.9589 | 0.9779 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 71.54 | 771.67 | 6750 | 10532 | 0.6409 | 0.7774 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 73.76 | 771.67 | 10439 | 10851 | 0.9620 | 0.9798 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 73.76 | 771.67 | 6817 | 10851 | 0.6282 | 0.7705 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 76.02 | 771.67 | 10804 | 11106 | 0.9727 | 0.9857 | MN20160304_L01 | I15 |